Marchetti, Claudia
Marchetti, Claudia
ROMA - Dipartimento di Scienze della vita e sanità pubblica
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study
2025 Marchetti, Claudia; Fagotti, Anna; Fruscio, R.; Cassani, C.; Incorvaia, L.; Perri, M. T.; Sassu, Carolina Maria; Camnasio, C. A.; Giudice, E.; Minucci, Angelo; Seca, M.; Arbustini, E.; Vertechy, L.; De Bonis, M.; Boccia, S. M.; Giannarelli, Diana; Salutari, Vanda; Distefano, M.; Ferrandina, Maria Gabriella; Nero, Camilla; Musacchio, L.; Russo, A.; Scambia, Giovanni; Lorusso, D.
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery
2025 Marchetti, Claudia; Ergasti, Raffaella; Capomacchia, Filippo Maria; Giannarelli, Diana; Mastrantoni, Luca; Pepe, Francesco; Apostol, Adriana Ionelia; Sassu, Carolina Maria; Nero, Camilla; Piermattei, Alessia; Zannoni, Gian Franco; Troncone, Giancarlo; Colomban, Olivier; Russo, Gianluca; Carrot, Aurore; Malapelle, Umberto; You, Benoit; Lorusso, Domenica; Scambia, Giovanni; Fagotti, Anna
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence
2025 Loverro, M.; Marchetti, Claudia; Salutari, Vanda; Giannarelli, Diana; Vertechy, L.; Capomacchia, F. M.; Caricato, Chiara; Campitelli, Maura; Panico, Camilla; Avesani, Giacomo; Cocciolillo, Fabrizio; Rosati, Andrea; Scambia, Giovanni; Fagotti, Anna
Value of frozen section to tailor surgical staging in apparent early-stage epithelial ovarian cancer
2025 Di Berardino, Stefano; Bizzarri, Nicolò; Ciancia, Marianna; Moro, Francesca; Padial Urtueta, Belen; Marchetti, Claudia; Zannoni, Gian Franco; Scambia, Giovanni; Fagotti, Anna
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status
2024 Marchetti, Claudia; Ataseven, Beyhan; Perrone, Anna M.; Cassani, Chiara; Fruscio, Robert; Sassu, Carolina Maria; Apostol, Adriana Ionelia; Harter, Philipp; De Iaco, Pierandrea; Camnasio, Cristina Angela; Moubarak, Malak; Giannarelli, Diana; Scambia, Giovanni; Fagotti, Anna
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients
2024 Bruno, Matteo; Apostol, Adriana Ionelia; Boccia, Serena Maria; Sassu, Carolina Maria; Lardino, Sara; Culcasi, Camilla; Lorusso, Domenica; Scambia, Giovanni; Fagotti, Anna; Marchetti, Claudia
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival?
2024 Sassu, Carolina Maria; Marchetti, Claudia; Russo, G.; Minucci, Angelo; Boccia, S. M.; Benato, Alberto; Nero, Camilla; Piermattei, Angelo; Mattogno, Pier Paolo; Giannarelli, Diana; Ferrandina, Maria Gabriella; Olivi, Alessandro; Fagotti, Anna; Scambia, Giovanni
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer
2024 Rosati, Andrea; De Rose, Agostino Maria; Gallotta, Valerio; Giannarelli, Diana; Ghirardi, Valentina; Pavone, Matteo; De Palma, Antonella; Conte, Carmine; Marchetti, Claudia; Gallucci, Valeria; Ardito, Francesco; Giuliante, Felice; Querleu, Denis; Scambia, Giovanni; Fagotti, Anna
New windows of surgical opportunity for gynecological cancers in the era of targeted therapies
2024 Peters, I.; Marchetti, Claudia; Scambia, Giovanni; Fagotti, Anna
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations
2023 Nebgen, D. R.; Domchek, S. M.; Kotsopoulos, J.; de Hullu, J. A.; Crosbie, E. J.; Paramanandam, V. S.; van Zanten, M. B.; Norquist, B. M.; Guise, T.; Rozenberg, S.; Kurian, A. W.; Pederson, H. J.; Yuksel, N.; Michaelson-Cohen, R.; Bober, S. L.; da SilvaFilho, A. L.; Johansen, N.; Guidozzi, F.; Evans, D. G.; Menon, U.; Kingsberg, S. A.; Powell, C. B.; Grandi, G.; Marchetti, Claudia; Jacobson, M.; Brennan, D. J.; Hickey, M.
Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis
2023 Peters, I. T. A.; Marchetti, Claudia; De Palma, Antonella; Giannarelli, Diana; Carcagnì, A.; Scambia, Giovanni; Fagotti, Anna
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial
2023 Musacchio, Lucia; Turinetto, Margherita; Arenare, Laura; Bartoletti, Michele; Califano, Daniela; Tuninetti, Valentina; Marchetti, Claudia; Cormio, Gennaro; Loizzi, Vera; Pisano, Carmela; Salutari, Vanda; Valabrega, Giorgio; Priolo, Domenico; Cecere, Sabrina Chiara; Ventriglia, Jole; Raspagliesi, Francesco; Perrone, Francesco; Fagotti, Anna; Lorusso, Domenica; Scambia, Giovanni; Pignata, Sandro
Origin of residual tumor masses in {BRCA}1/2-driven ovarian carcinomas treated by neoadjuvant chemotherapy: selection of preexisting {BRCA}1/2-proficient tumor cells but not the gain of second {ORF}-restoring mutation
2023 34., Sokolenko A; Preobrazhenskaya, E; Marchetti, Claudia; Piermattei, Angelo; Zagrebin, F; Kuligina, E; Gorodnova, T; Pavone, Matteo; Ivantsov, A; Bizin, I; Scambia, Giovanni; Berlev, I; Fagotti, Anna; Imyanitov, E
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients
2023 Marchetti, Claudia; Ataseven, Beyhan; Cassani, Chiara; Sassu, Carolina Maria; Congedo, Luigi; D'Indinosante, Marco; Cappuccio, Serena; Rhiem, Kerstin; Hahnen, Eric; Lucci Cordisco, Emanuela; Arbustini, Eloisa; Harter, Philipp; Minucci, Angelo; Scambia, Giovanni; Fagotti, Anna
Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850)
2023 Marchetti, Claudia; Giannarelli, Diana; Vizzielli, Giuseppe; Ferrandina, Maria Gabriella; Tortorella, Lucia; Fanfani, Francesco; Costantini, Barbara; Pasciuto, Tina; Scambia, Giovanni; Fagotti, Anna
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer
2023 Conte, Carmine; Marchetti, Claudia; Loverro, Matteo; Giudice, M. T.; Rosati, A.; Gallotta, Valerio; Scambia, Giovanni; Fagotti, Anna
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors
2023 Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors
2023 Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors
2023 Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
2023 Incorvaia, L; Perez, A; Marchetti, Claudia; Brando, C; Gristina, V; Cancelliere, D; Pivetti, A; Contino, S; Di Giovanni, E; Barraco, N; Bono, M; Giurintano, A; Russo, Tdb; Gottardo, A; Cutaia, S; Pedone, E; Peri, M; Corsini, Lr; Fanale, D; Galvano, A; Scambia, Giovanni; Badalamenti, G; Russo, A; Bazan, V
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2025 | Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study | Marchetti, Claudia; Fagotti, Anna; Fruscio, R.; Cassani, C.; Incorvaia, L.; Perri, M. T.; Sassu, Carolina Maria; Camnasio, C. A.; Giudice, E.; Minucci, Angelo; Seca, M.; Arbustini, E.; Vertechy, L.; De Bonis, M.; Boccia, S. M.; Giannarelli, Diana; Salutari, Vanda; Distefano, M.; Ferrandina, Maria Gabriella; Nero, Camilla; Musacchio, L.; Russo, A.; Scambia, Giovanni; Lorusso, D. | |
| 1-gen-2025 | Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery | Marchetti, Claudia; Ergasti, Raffaella; Capomacchia, Filippo Maria; Giannarelli, Diana; Mastrantoni, Luca; Pepe, Francesco; Apostol, Adriana Ionelia; Sassu, Carolina Maria; Nero, Camilla; Piermattei, Alessia; Zannoni, Gian Franco; Troncone, Giancarlo; Colomban, Olivier; Russo, Gianluca; Carrot, Aurore; Malapelle, Umberto; You, Benoit; Lorusso, Domenica; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2025 | Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence | Loverro, M.; Marchetti, Claudia; Salutari, Vanda; Giannarelli, Diana; Vertechy, L.; Capomacchia, F. M.; Caricato, Chiara; Campitelli, Maura; Panico, Camilla; Avesani, Giacomo; Cocciolillo, Fabrizio; Rosati, Andrea; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2025 | Value of frozen section to tailor surgical staging in apparent early-stage epithelial ovarian cancer | Di Berardino, Stefano; Bizzarri, Nicolò; Ciancia, Marianna; Moro, Francesca; Padial Urtueta, Belen; Marchetti, Claudia; Zannoni, Gian Franco; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2024 | Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status | Marchetti, Claudia; Ataseven, Beyhan; Perrone, Anna M.; Cassani, Chiara; Fruscio, Robert; Sassu, Carolina Maria; Apostol, Adriana Ionelia; Harter, Philipp; De Iaco, Pierandrea; Camnasio, Cristina Angela; Moubarak, Malak; Giannarelli, Diana; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2024 | Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients | Bruno, Matteo; Apostol, Adriana Ionelia; Boccia, Serena Maria; Sassu, Carolina Maria; Lardino, Sara; Culcasi, Camilla; Lorusso, Domenica; Scambia, Giovanni; Fagotti, Anna; Marchetti, Claudia | |
| 1-gen-2024 | Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? | Sassu, Carolina Maria; Marchetti, Claudia; Russo, G.; Minucci, Angelo; Boccia, S. M.; Benato, Alberto; Nero, Camilla; Piermattei, Angelo; Mattogno, Pier Paolo; Giannarelli, Diana; Ferrandina, Maria Gabriella; Olivi, Alessandro; Fagotti, Anna; Scambia, Giovanni | |
| 1-gen-2024 | Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer | Rosati, Andrea; De Rose, Agostino Maria; Gallotta, Valerio; Giannarelli, Diana; Ghirardi, Valentina; Pavone, Matteo; De Palma, Antonella; Conte, Carmine; Marchetti, Claudia; Gallucci, Valeria; Ardito, Francesco; Giuliante, Felice; Querleu, Denis; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2024 | New windows of surgical opportunity for gynecological cancers in the era of targeted therapies | Peters, I.; Marchetti, Claudia; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2023 | Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations | Nebgen, D. R.; Domchek, S. M.; Kotsopoulos, J.; de Hullu, J. A.; Crosbie, E. J.; Paramanandam, V. S.; van Zanten, M. B.; Norquist, B. M.; Guise, T.; Rozenberg, S.; Kurian, A. W.; Pederson, H. J.; Yuksel, N.; Michaelson-Cohen, R.; Bober, S. L.; da SilvaFilho, A. L.; Johansen, N.; Guidozzi, F.; Evans, D. G.; Menon, U.; Kingsberg, S. A.; Powell, C. B.; Grandi, G.; Marchetti, Claudia; Jacobson, M.; Brennan, D. J.; Hickey, M. | |
| 1-gen-2023 | Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis | Peters, I. T. A.; Marchetti, Claudia; De Palma, Antonella; Giannarelli, Diana; Carcagnì, A.; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2023 | Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial | Musacchio, Lucia; Turinetto, Margherita; Arenare, Laura; Bartoletti, Michele; Califano, Daniela; Tuninetti, Valentina; Marchetti, Claudia; Cormio, Gennaro; Loizzi, Vera; Pisano, Carmela; Salutari, Vanda; Valabrega, Giorgio; Priolo, Domenico; Cecere, Sabrina Chiara; Ventriglia, Jole; Raspagliesi, Francesco; Perrone, Francesco; Fagotti, Anna; Lorusso, Domenica; Scambia, Giovanni; Pignata, Sandro | |
| 1-gen-2023 | Origin of residual tumor masses in {BRCA}1/2-driven ovarian carcinomas treated by neoadjuvant chemotherapy: selection of preexisting {BRCA}1/2-proficient tumor cells but not the gain of second {ORF}-restoring mutation | 34., Sokolenko A; Preobrazhenskaya, E; Marchetti, Claudia; Piermattei, Angelo; Zagrebin, F; Kuligina, E; Gorodnova, T; Pavone, Matteo; Ivantsov, A; Bizin, I; Scambia, Giovanni; Berlev, I; Fagotti, Anna; Imyanitov, E | |
| 1-gen-2023 | Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients | Marchetti, Claudia; Ataseven, Beyhan; Cassani, Chiara; Sassu, Carolina Maria; Congedo, Luigi; D'Indinosante, Marco; Cappuccio, Serena; Rhiem, Kerstin; Hahnen, Eric; Lucci Cordisco, Emanuela; Arbustini, Eloisa; Harter, Philipp; Minucci, Angelo; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2023 | Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) | Marchetti, Claudia; Giannarelli, Diana; Vizzielli, Giuseppe; Ferrandina, Maria Gabriella; Tortorella, Lucia; Fanfani, Francesco; Costantini, Barbara; Pasciuto, Tina; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2023 | Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer | Conte, Carmine; Marchetti, Claudia; Loverro, Matteo; Giudice, M. T.; Rosati, A.; Gallotta, Valerio; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2023 | Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors | Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica | |
| 1-gen-2023 | Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors | Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica | |
| 1-gen-2023 | Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors | Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica | |
| 1-gen-2023 | Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? | Incorvaia, L; Perez, A; Marchetti, Claudia; Brando, C; Gristina, V; Cancelliere, D; Pivetti, A; Contino, S; Di Giovanni, E; Barraco, N; Bono, M; Giurintano, A; Russo, Tdb; Gottardo, A; Cutaia, S; Pedone, E; Peri, M; Corsini, Lr; Fanale, D; Galvano, A; Scambia, Giovanni; Badalamenti, G; Russo, A; Bazan, V |